KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Equity Ratio (2016 - 2025)

Novartis Ag's Equity Ratio history spans 10 years, with the latest figure at 0.42 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 3.66% to 0.42 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.42, a 3.66% decrease, with the full-year FY2025 number at 0.42, down 3.66% from a year prior.
  • Equity Ratio hit 0.42 in Q4 2025 for Novartis Ag, down from 0.43 in the prior quarter.
  • Over the last five years, Equity Ratio for NVS hit a ceiling of 0.51 in Q4 2021 and a floor of 0.42 in Q4 2025.
  • Historically, Equity Ratio has averaged 0.47 across 5 years, with a median of 0.47 in 2023.
  • Biggest five-year swings in Equity Ratio: soared 4733.89% in 2021 and later fell 7.74% in 2024.
  • Tracing NVS's Equity Ratio over 5 years: stood at 0.51 in 2021, then fell by 1.69% to 0.51 in 2022, then dropped by 7.55% to 0.47 in 2023, then fell by 7.74% to 0.43 in 2024, then fell by 3.66% to 0.42 in 2025.
  • Business Quant data shows Equity Ratio for NVS at 0.42 in Q4 2025, 0.43 in Q4 2024, and 0.47 in Q4 2023.